Overview
Burkholderia gladioli is a versatile bacterium within the Burkholderiaceae family, first identified in association with gladiolus plants. It exhibits both beneficial and pathogenic traits, depending on the strain and environment. While some strains cause crop diseases (e.g., sheath rot in rice), others are exploited for biocontrol against fungal pathogens or for producing antibiotics like gladiolin. Genomic studies reveal its adaptability, with plasmids encoding virulence factors and metabolic pathways for niche specialization. Research continues to explore its dual roles in agriculture and medicine, balancing its risks and potential applications.
Key Features
B. gladioli is characterized by its aerobic metabolism, flagella-driven motility, and ability to thrive in diverse environments, including soil, water, and plant tissues. It produces extracellular enzymes like lipases and chitinases, aiding in nutrient acquisition and pathogenicity. Notably, certain strains synthesize secondary metabolites with antimicrobial properties, making them candidates for drug development. However, its biofilm formation and resistance to multiple antibiotics raise concerns in clinical settings, particularly for cystic fibrosis patients.
Application Areas
In agriculture, B. gladioli strains are studied as biocontrol agents against fungal pathogens such as Fusarium, leveraging their antifungal compound production. For example, strain BSR3 is used to protect crops like rice and onions. In medicine, its metabolites (e.g., enacyloxins) show promise against drug-resistant bacteria. Industrial applications include enzyme production for biodegradation processes. However, strain-specific risk assessments are critical due to potential human infections.
Precautions
While B. gladioli has beneficial uses, it is classified as a Risk Group 2 pathogen in labs due to opportunistic infections in immunocompromised individuals. Proper containment (BSL-2) and personal protective equipment (PPE) are mandatory during handling. In agriculture, avoid using pathogenic strains near food crops. Regulatory approvals are required for field applications to prevent unintended ecological impacts, such as disrupting soil microbiota.
B2B Procurement Guide
Research institutions and biotech firms typically source B. gladioli strains from culture collections (e.g., ATCC, DSMZ) or academic collaborators. Key procurement factors include strain certification (e.g., genomic sequencing data), intended use (research vs. field trials), and compliance with local biosafety laws. For industrial-scale applications, partner with specialized suppliers offering characterized strains with documented safety and efficacy profiles. Pilot testing is recommended to validate performance in target environments.
Related Manufacturers
- 主营：研突破、转座酶、重组酶、大肠杆菌、微球菌核酸酶、连接酶、研试剂、(5×)(with、recombinant、结合蛋白、胶体染料、核酸染料、助力科研、泛素蛋白、实验室用品、重组肠激酶、电泳缓冲液、拓扑异构酶、热敏磷酸酶、检测试剂盒、全能核酸酶、核酸外切酶、核酸内切酶、连接试剂盒、碱性磷酸酶
- 主营：科研试剂、高效试剂
- 主营：抗体、感受态、培养基、试剂盒、层析柱、填料、生物试剂、化学试剂
- 主营：微生物菌种、标准菌株、益生菌、食用菌